Answers are grounded in this paper and cite their sources.
Selective B cell cytotoxicity coupled with slow repopulation kinetics results in long-term, memory B cell depletion by cladribine. These may offer a new target, possibly with potential biomarker activity, for future drug development.
No takes yet. Share an insight, caveat, or question.
Ceronie et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: